| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/12/2000 | EP0970955A1 Paroxetine methanesulfonate |
| 01/12/2000 | EP0970741A1 O/w/o type multiphase emulsion |
| 01/12/2000 | EP0970705A1 Agglomerate of spherical polyvalent-metal alginate particulates, controlled-release preparation comprising difficultly soluble drug supported on said agglomerate, and processes for producing the both |
| 01/12/2000 | EP0970704A1 Silicone core long term androgen delivery implant |
| 01/12/2000 | EP0970703A1 Stable, aqueous alfa interferon solution formulations |
| 01/12/2000 | EP0970700A2 Gallium containing medicaments for enhancing wound healing and tissue repair |
| 01/12/2000 | EP0970131A1 Particulate drug carriers |
| 01/12/2000 | EP0969883A1 Implant for subcutaneous or intradermal injection |
| 01/12/2000 | EP0969876A2 Delivery system for gene therapy to the brain |
| 01/12/2000 | EP0969872A2 Induction of b cell tolerance |
| 01/12/2000 | EP0969871A1 Homogenous water-free formulations containing glycerophospholipids and polar or lipophilic substances, method for the production thereof |
| 01/12/2000 | EP0969860A1 Method for preparation of a therapeutic powder through coprecipitation of insulin and absorption enhancer |
| 01/12/2000 | EP0969857A1 Pharmaceutical compositions |
| 01/12/2000 | EP0969856A1 Hydrophilic binary systems for the administration of cyclosporine |
| 01/12/2000 | EP0969847A1 Tazarotene and corticosteroid treatment for psoriasis |
| 01/12/2000 | EP0969846A1 Compositions and methods for reducing ocular hypertension |
| 01/12/2000 | EP0969844A1 Administration of an injectable antibiotic in the ear of an animal |
| 01/12/2000 | EP0969842A1 Pharmaceutical composition |
| 01/12/2000 | EP0969838A1 Product and method for the treatment of hyperlipidemia |
| 01/12/2000 | EP0969837A1 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
| 01/12/2000 | EP0969836A1 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine |
| 01/12/2000 | EP0969832A1 Pharmaceutical composition for oral administration of a n-piperidino- 3-pyrazolecarboxamide derivative, its salts and their solvates |
| 01/12/2000 | EP0969831A1 Nasal melatonin composition |
| 01/12/2000 | EP0969827A1 Mixture of primary fatty acids obtained from sugar cane wax |
| 01/12/2000 | EP0969825A1 Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium |
| 01/12/2000 | EP0969821A1 Pellets having a core coated with an antifungal and a polymer |
| 01/12/2000 | EP0969820A2 Implantable delivery device with self adjustable exit port |
| 01/12/2000 | EP0969819A2 New crystalline form of omeprazole |
| 01/12/2000 | EP0969818A1 Dosage forms comprising separate portions of r- and s-enantiomers |
| 01/12/2000 | EP0969817A1 Dosage forms having improved release properties |
| 01/12/2000 | EP0969816A1 Preparation of powder agglomerates |
| 01/12/2000 | EP0969815A2 Pharmaceutical compositions |
| 01/12/2000 | EP0969814A1 Opthalmic non-irritating iodine medicament and method |
| 01/12/2000 | EP0969813A2 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker |
| 01/12/2000 | EP0969812A1 Ophthalmic compositions including glycerin and propylene glycol |
| 01/12/2000 | EP0969807A2 Chitosane microspheres |
| 01/12/2000 | EP0969806A1 Keratotic plug remover |
| 01/12/2000 | EP0969804A1 Process for preparing silicone elastomer compositions |
| 01/12/2000 | EP0969803A1 Emulsifier-free finely dispersed systems of the water-in-oil type |
| 01/12/2000 | EP0969802A1 Emulsifier-free finely dispersed systems of the water-in-oil type |
| 01/12/2000 | EP0969775A1 Bone marrow as a site for transplantation |
| 01/12/2000 | EP0778785B1 Methods and apparatus for the delivery of solid drug compositions |
| 01/12/2000 | EP0731698B1 Modafinil having defined particle size |
| 01/12/2000 | EP0729362B1 TRANSDERMAL COMPOSITION OF N- N- 5- 4-(AMINOIMINOMETHYL)PHENYL]-1-OXOPENTYL]-L-alpha-ASPARTYL]-L-PHENYLALANINE OR ITS ESTERS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
| 01/12/2000 | EP0722341B1 Non-ionic surfarctant vesicles comprising antigens |
| 01/12/2000 | CN2357748Y Yaoqibao inhalator |
| 01/12/2000 | CN1241198A Polymer gel composition and uses therefor |
| 01/12/2000 | CN1241179A Micro-particulate form of tetrahydropyridin deriv. |
| 01/12/2000 | CN1241167A Fine cisplatin powder and process for production thereof |
| 01/12/2000 | CN1241139A Method of producing sustained-release preparation |
| 01/12/2000 | CN1241132A Dermatologic preparation |
| 01/12/2000 | CN1240663A Plaster for treating trauma, bone fracture and rheumatism and its preparing process |
| 01/12/2000 | CN1240650A Compound metronidazole suppository |
| 01/12/2000 | CN1240648A Transition metal complexes of non steroidal anti-inflammatory drugs |
| 01/12/2000 | CN1240646A Injectable composition of non-steroidal anti-inflammatory drugs |
| 01/12/2000 | CN1240645A Pellet formulations |
| 01/12/2000 | CN1240641A Ointment for treating hircus and its preparing process |
| 01/12/2000 | CN1240639A Composition of olefin copolymer comprising controlled crystallization and use of such coplymer |
| 01/12/2000 | CN1048248C Crystal of pyrrolidylthiocarbapenem deriv. lyophilized preparation contg. said crystal, and process for producing same |
| 01/12/2000 | CN1048182C Method for preparing pharmaceutical carrier of fat emulsion |
| 01/12/2000 | CN1048178C Hair blackening liquid/paste, and preparing method thereof |
| 01/12/2000 | CN1048167C Chinese medicine ointment for treating gynaopathly |
| 01/12/2000 | CN1048163C Styptical medical paper |
| 01/12/2000 | CN1048157C Compouded injection of ribonucleic acid and heparin |
| 01/11/2000 | US6013679 Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use |
| 01/11/2000 | US6013670 Administering c1-c6 alkanoyl carnitine or salt to treat chronic inflammatory bowel disease |
| 01/11/2000 | US6013665 Administering to a animal a triglyceride containg atleast 33 to 70 weight% medium acyl chain having 4 to 12 carbon atom, 30 to 67 weight % long acyl chain having more than 12 carbon atom, an equivalent carbon number 30 to 48 |
| 01/11/2000 | US6013657 Pharmaceutical compositions containing mupirocin |
| 01/11/2000 | US6013636 Mixture with vegetable oil and cosolvent |
| 01/11/2000 | US6013619 Applying gas positive end-expiratory pressure with ventilator into lung section of mammal, instilling lavage composition containing dilute surfactant in a pharmaceutically acceptable aqueous medium into lung, removing pulmonary fluid |
| 01/11/2000 | US6013306 Attaching low aspect ratio tablet to nozzle through the use of vacuum, inverting the tablet and nozzle into coating solution; vacuum shuts off if tablet is not attached to nozzle |
| 01/11/2000 | US6013286 Encapsulated bioactive substances |
| 01/11/2000 | US6013285 Pumping an albumin protein solution and alcohol solution to first mixing chamber, mixing together to form protein spheres solution, pumping spheres to a second chamber, pumping crossliking agent and crosskinking the protein sphere |
| 01/11/2000 | US6013284 Synthetic particulate vectors and preparation process |
| 01/11/2000 | US6013282 Enteric film coating compositions, method of coating therewith, and coated forms |
| 01/11/2000 | US6013281 Method of making a pharmaceutical dosage form comprising a proton pump inhibitor |
| 01/11/2000 | US6013280 Dosage of an analgesic agent and one or more polymeric solubizing agent containing a diblock copolymer of ethylene oxide and propylene oxide; improved dissolution and shorter time to maximum plasma concentration |
| 01/11/2000 | US6013278 Liposomal antineoplaston therapies with markedly improved antineoplastic activity |
| 01/11/2000 | US6013277 Compositions for topical treatment of erectile impotence |
| 01/11/2000 | US6013276 Transdermal matrix system |
| 01/11/2000 | US6013258 Immunogenic peptides from the HPV E7 protein |
| 01/11/2000 | US6013245 Aerosol formulation containing beclomethasone dipropionate and 1,1,1,2,3,3,3-heptafluoro-n-propane as propellant |
| 01/11/2000 | US6013240 Nucleic acid containing composition, preparation and uses of same |
| 01/11/2000 | US6013216 Mixing powder of primary particles and mist of binder by means of fluidizing air flow; collecting mixture on flat filter; peeling powder layer from filter surface; returning fragments to fluidizing air flow; repeating procedure |
| 01/11/2000 | US6013206 Dissolving lipid in a methanol/ethanol/water solvent with specific ratios of methanol and ethanol; allowing microtubules to self-assemble in the solvent; separating lipid microtubules from solvent |
| 01/11/2000 | US6012375 Aircraft infrared guided defense missile system |
| 01/11/2000 | US6012268 Method of producing products from polymer materials having a medicamentous depot effect |
| 01/11/2000 | CA2247114C Liquid oral compositions comprising a calcium compound and an acidulant |
| 01/11/2000 | CA2196698C Polyesters |
| 01/11/2000 | CA2162001C Salicylic acid derivative used for the stabilization of an oil-in-water emulsion |
| 01/11/2000 | CA2150832C Antibiotic formulation and use for bacterial infections |
| 01/11/2000 | CA2065311C Solid matrix system for transdermal drug delivery |
| 01/11/2000 | CA2057909C Cutaneous delivery of organic materials |
| 01/06/2000 | WO2000000550A1 A membrane or matrix for controlling the permeation rate of drugs |
| 01/06/2000 | WO2000000492A1 FINE POWDER OF L-α-AMINOADIPIC ACID DERIVATIVE, ORAL SOLID PREPARATIONS CONTAINING THE SAME, AND METHOD FOR TREATMENT OF BULK POWDERS |
| 01/06/2000 | WO2000000222A1 Thermosensitive biodegradable hydrogels for sustained delivery of biologically active agents |
| 01/06/2000 | WO2000000221A1 Water soluble dry compositions |
| 01/06/2000 | WO2000000220A1 Pharmaceutical composition containing an ester or amide pla2 inhibitor |
| 01/06/2000 | WO2000000218A1 Mucosal targeting immunisation |
| 01/06/2000 | WO2000000215A1 Particulate delivery systems and methods of use |